• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Quantitative GLC determination of cyclophosphamide and isophosphamide in biological specimens.

作者信息

Pantarotto C, Bossi A, Belvedere G, Martini A, Donelli M G, Frigerio A

出版信息

J Pharm Sci. 1974 Oct;63(10):1554-8. doi: 10.1002/jps.2600631014.

DOI:10.1002/jps.2600631014
PMID:4436788
Abstract
摘要

相似文献

1
Quantitative GLC determination of cyclophosphamide and isophosphamide in biological specimens.生物样本中环磷酰胺和异环磷酰胺的定量气相色谱法测定
J Pharm Sci. 1974 Oct;63(10):1554-8. doi: 10.1002/jps.2600631014.
2
Some studies of the active intermediates formed in the microsomal metabolism of cyclophosphamide and isophosphamide.一些关于环磷酰胺和异环磷酰胺微粒体代谢过程中形成的活性中间体的研究。
Biochem Pharmacol. 1974 Jan 1;23(1):115-29. doi: 10.1016/0006-2952(74)90318-9.
3
Gas chromatographic method for the determination of plasma isophosphamide (NSC-109724).气相色谱法测定血浆异环磷酰胺（NSC - 109724）
Cancer Chemother Rep. 1972 Dec;56(6):721-3.
4
Isophosphamide as a new acrolein-producing antineoplastic isomer of cyclophosphamide.
Cancer Res. 1972 Nov;32(11):2519-23.
5
In vitro activation of isophosphamide (NSC-109724), a new oxazaphosphorine, by rat liver microsomes.大鼠肝微粒体对新型恶唑磷（异环磷酰胺，NSC - 109724）的体外激活作用。
Cancer Chemother Rep. 1972 Oct;56(5):603-10.
6
Studies on the disposition of cyclophosphamide (NSC-26271) in tumor-bearing mice by means of gas chromatography-chemical ionization-mass fragmentography.
Cancer Treat Rep. 1976 Apr;60(4):493-500.
7
A procedure for monitoring cyclophosphamide and isophosphamide in biological samples.一种监测生物样品中环磷酰胺和异环磷酰胺的方法。
Br J Clin Pharmacol. 1978 Oct;6(4):373-6. doi: 10.1111/j.1365-2125.1978.tb00869.x.
8
Metabolism of iphosphamide (2-(2-chloroethylamino)-3-(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide) and production of a toxic iphosphamide metabolite.
Cancer Res. 1973 May;33(5):1016-22.
9
Synthesis and metabolic behavior of the suggested active species of isophosphamide having cytostatic activity.
J Med Chem. 1974 Nov;17(11):1237-9. doi: 10.1021/jm00257a024.
10
Cardiac and pulmonary effects of high doses of cyclophosphamide and isophosphamide.高剂量环磷酰胺和异环磷酰胺对心脏和肺部的影响。
Cancer Res. 1974 Jul;34(7):1586-91.

引用本文的文献

1
Repeated investigations of cyclophosphamide disposition in myeloma patients receiving intermittent chemotherapy.对接受间歇性化疗的骨髓瘤患者环磷酰胺处置情况的反复研究。
Br J Clin Pharmacol. 1980 Sep;10(3):281-5. doi: 10.1111/j.1365-2125.1980.tb01756.x.
2
Decreased plasma half-life of cyclophosphamide during repeated high-dose administration.
Cancer Chemother Pharmacol. 1983;10(3):192-3. doi: 10.1007/BF00255760.
3
Pharmacokinetics of high-dose cyclophosphamide in patients with metastatic bronchogenic carcinoma.高剂量环磷酰胺在转移性支气管癌患者中的药代动力学
Cancer Chemother Pharmacol. 1983;11(3):196-9. doi: 10.1007/BF00254204.
4
Urinary cyclophosphamide assay as a method for biological monitoring of occupational exposure to cyclophosphamide.尿中环磷酰胺检测作为职业性接触环磷酰胺生物监测的一种方法。
Int Arch Occup Environ Health. 1986;58(2):151-5. doi: 10.1007/BF00380766.
5
Subcutaneous continuous infusion of ifosfamide and cyclophosphamide in ambulatory cancer patients: bioavailability and feasibility.门诊癌症患者皮下持续输注异环磷酰胺和环磷酰胺：生物利用度与可行性
J Cancer Res Clin Oncol. 1991;117 Suppl 4(Suppl 4):S129-34. doi: 10.1007/BF01613217.
6
Detection of contamination with antineoplastic agents in a hospital pharmacy department.
Pharm Weekbl Sci. 1992 Feb 21;14(1):16-22. doi: 10.1007/BF01989220.
7
Pharmacokinetics of intravenous cyclophosphamide in man, estimated by gas-liquid chromatography.通过气液色谱法估算人静脉注射环磷酰胺的药代动力学。
Cancer Chemother Pharmacol. 1978;1(4):229-31. doi: 10.1007/BF00257155.
8
A procedure for monitoring cyclophosphamide and isophosphamide in biological samples.一种监测生物样品中环磷酰胺和异环磷酰胺的方法。
Br J Clin Pharmacol. 1978 Oct;6(4):373-6. doi: 10.1111/j.1365-2125.1978.tb00869.x.
9
The disposition of cyclophosphamide in a group of myeloma patients.环磷酰胺在一组骨髓瘤患者中的处置情况。
Cancer Chemother Pharmacol. 1979;3(4):253-9. doi: 10.1007/BF00254741.
10
Clinical pharmacokinetics of cyclophosphamide.环磷酰胺的临床药代动力学
Clin Pharmacokinet. 1979 Sep-Oct;4(5):380-94. doi: 10.2165/00003088-197904050-00004.